Zobrazeno 1 - 10
of 31
pro vyhledávání: '"T M Sasaki"'
Publikováno v:
Clinical Transplantation. 16:30-33
Tacrolimus inhibits lymphocyte responses by blocking calcium-dependent signalling pathways important in IL-2 generation. Daclizumab, a humanized monoclonal antibody, binds with high affinity to the Tac subunit of the IL-2receptor complex. We reasoned
Publikováno v:
Clinical Transplantation. 14:409-412
Daclizumab (DAC) is a molecularly engineered humanized IgGa monoclonal Ab directed against the alpha chain of the interleukin-2 receptor (IL2R). Inhibiting the amplification of the immune response by blocking IL2R can reduce the frequency of acute re
Publikováno v:
Nephrology Dialysis Transplantation. 12:827-830
Publikováno v:
The American Journal of Surgery. 177:368-370
Background: Open live donor nephrectomy is safe and provides kidneys of excellent quality. The complexity of the laparoscopic donor technique has raised considerable concerns. Method: Twenty-six laparoscopic live donor nephrectomies were done from Oc
Publikováno v:
Clinical Transplantation. 13:123-125
In a retrospective analysis we compared the outcome of a group of 63 kidney or kidney/pancreas transplant recipients who were transplanted between June 1994 and February 1997 and received either tacrolimus (FK, n = 22) or Neoral (NEO, n = 41) as part
Autor:
Silverio Cabellon, W.D. Adams, David R. Brunetti, Gary Friedlander, Reza Ghaseiman, Mitchell Edson, T M Sasaki, Jay Dunca Harviel
Publikováno v:
Urology. 43:235-237
Bilateral renal artery thrombosis is a rare but traumatic injury that is most commonly caused by sudden deceleration. Traditional methods of repair (e.g., in situ repair, bypass graft, and thrombectomy) have poor success rates. This report is the fir
Publikováno v:
Transplantation. 71(12)
There is controversy whether laparoscopic donor nephrectomy (LDN) is the procedure of choice for live kidney donors. The purpose of this survey therefore was to determine the current practices, attitudes, and plans regarding LDN in high-volume renal
Publikováno v:
Clinical transplantation. 14(4 Pt 2)
Daclizumab (DAC) is a molecularly engineered humanized IgGa monoclonal Ab directed against the alpha chain of the interleukin-2 receptor (IL2R). Inhibiting the amplification of the immune response by blocking IL2R can reduce the frequency of acute re
Autor:
Frederick C. Finelli, Diana Y. Barhyte, Deneen Fowlkes, T M Sasaki, Julie Trollinger, Jimmy A. Light, Elizabeth Bugarin
Publikováno v:
Archives of surgery (Chicago, Ill. : 1960). 135(8)
Hypothesis The posttransplantation renal function outcomes between consecutive open donor and laparoscopic donor nephrectomies (LDNs) are similar and affect living donation. Design Using the medical records of renal living donor–recipient pairs, 36
Publikováno v:
Transplantation proceedings. 32(1)